Breaking News Instant updates and real-time market news.

MTN

Vail Resorts

$221.87 /

+4.59 (+2.11%)

10:27
08/24/20
08/24
10:27
08/24/20
10:27

Capacity restrictions amid ski season likely to hurt Vail Resorts, WSJ reports

The coronavirus is likely to still be circulating for most of the upcoming ski season, hurting companies like Vail Resorts, The Wall Street Journal's Justin Lahart reports. There was an outbreak in Idaho of the pandemic, where more than 100 people became infected, and if another outbreak at a ski area occurs, it could cast a pall over the entire industry, according to the report. Capacity restrictions on lifts and restaurants are likely, and that will place limits on revenue, it adds. Reference Link

  • 24

    Aug

MTN Vail Resorts
$221.87 /

+4.59 (+2.11%)

06/08/20 Truist
Vail Resorts price target raised to $233 from $185 at SunTrust
06/05/20 KeyBanc
Vail Resorts price target raised to $225 from $200 at KeyBanc
06/05/20 Deutsche Bank
Vail Resorts price target lowered to $175 from $201 at Deutsche Bank
06/01/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Upgrade
Banco Macro upgraded to Buy from Reduce at HSBC » 05:14
09/25/20
09/25
05:14
09/25/20
05:14
BMA

Banco Macro

$14.61 /

+1.23 (+9.19%)

HSBC analyst Carlos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMA Banco Macro
$14.61 /

+1.23 (+9.19%)

07/21/20 HSBC
Banco Macro downgraded to Reduce from Hold at HSBC
01/17/20 Scotiabank
Banco Macro downgraded to Underperform from Sector Perform at Scotiabank
12/09/19 Itau BBA
Banco Macro downgraded to Underperform from Market Perform at Itau BBA
09/26/19 Scotiabank
Banco Macro upgraded to Sector Perform from Underperform at Scotiabank
Upgrade
Banco BBVA Argentina upgraded to Hold from Reduce at HSBC » 05:14
09/25/20
09/25
05:14
09/25/20
05:14
BBAR

Banco BBVA Argentina

$2.64 /

+0.235 (+9.79%)

HSBC analyst Carlos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBAR Banco BBVA Argentina
$2.64 /

+0.235 (+9.79%)

07/21/20 HSBC
Banco BBVA Argentina downgraded to Reduce from Hold at HSBC
Upgrade
4imprint Group upgraded to Buy from Hold at HSBC » 05:13
09/25/20
09/25
05:13
09/25/20
05:13
FRRFF

4imprint Group

$0.00 /

+ (+0.00%)

HSBC analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Nestle upgraded to Buy from Hold at HSBC » 05:12
09/25/20
09/25
05:12
09/25/20
05:12
NSRGY

Nestle

$0.00 /

+ (+0.00%)

HSBC analyst Jeremy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSRGY Nestle
$0.00 /

+ (+0.00%)

NSRGY Nestle
$0.00 /

+ (+0.00%)

09/01/20 Credit Suisse
Aimmune price target raised to $34.50 from $14 at Credit Suisse
08/31/20 Roth Capital
Nestle acquisition of Aimmune could be good for shareholders, says Roth Capital
08/31/20 Piper Sandler
Aimmune downgraded to Neutral from Overweight at Piper Sandler
08/04/20 JPMorgan
Nestle price target raised to CHF 123 from CHF 116 at JPMorgan
NSRGY Nestle
$0.00 /

+ (+0.00%)

NSRGY Nestle
$0.00 /

+ (+0.00%)

NSRGY Nestle
$0.00 /

+ (+0.00%)

Upgrade
One Gas upgraded to Buy from Neutral at Mizuho » 05:12
09/25/20
09/25
05:12
09/25/20
05:12
OGS

One Gas

$67.13 /

+0.36 (+0.54%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OGS One Gas
$67.13 /

+0.36 (+0.54%)

08/20/20 UBS
One Gas upgraded to Buy from Neutral at UBS
08/11/20
Fly Intel: Top five analyst upgrades
08/11/20 Wells Fargo
One Gas upgraded to Overweight at Wells Fargo
08/11/20 Wells Fargo
One Gas upgraded to Overweight from Equal Weight at Wells Fargo
OGS One Gas
$67.13 /

+0.36 (+0.54%)

Hot Stocks
Ipsen appoints Philippe Lopes-Fernandes as chief business officer » 05:10
09/25/20
09/25
05:10
09/25/20
05:10
IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, MRK

Merck

$83.17 /

+0.54 (+0.65%)

Ipsen (IPSEY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$0.00 /

+ (+0.00%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

09/21/20 Kepler Cheuvreux
Ipsen downgraded to Reduce from Hold at Kepler Cheuvreux
09/01/20 Morgan Stanley
Ipsen price target raised to EUR 101 from EUR 90 at Morgan Stanley
08/26/20 JPMorgan
JPMorgan backs Overweight on Ipsen after palovarotene data
08/04/20 UBS
Ipsen price target raised to EUR 101 from EUR 99 at UBS
MRK Merck
$83.17 /

+0.54 (+0.65%)

09/24/20 Roth Capital
Merck data suggests 'another shot on goal' for Jounce, says Roth Capital
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
MRK Merck
$83.17 /

+0.54 (+0.65%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

Upgrade
H2O Innovation upgraded to Buy from Speculative Buy at Industrial Alliance » 05:10
09/25/20
09/25
05:10
09/25/20
05:10
HEOFF

H2O Innovation

$0.00 /

+ (+0.00%)

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

09/21/20 Desjardins
H2O Innovation initiated with a Buy at Desjardins
HEOFF H2O Innovation
$0.00 /

+ (+0.00%)

Recommendations
CymaBay beating Genfit in primary biliary cholangitis race, says Piper Sandler » 05:08
09/25/20
09/25
05:08
09/25/20
05:08
CBAY

CymaBay

$6.35 /

+0.125 (+2.01%)

, GNFT

Genfit

$3.67 /

-0.28 (-7.09%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

GNFT Genfit
$3.67 /

-0.28 (-7.09%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

09/09/20 B. Riley FBR
CymaBay price target raised to $13 from $9 at B. Riley FBR
08/27/20 Piper Sandler
Piper Sandler 'astonished' by seladelpar's long-term benefits
08/25/20 Citi
CymaBay price target raised to $9 from $7 at Citi
08/04/20 H.C. Wainwright
CymaBay price target raised to $13 from $9 at H.C. Wainwright
GNFT Genfit
$3.67 /

-0.28 (-7.09%)

08/05/20 H.C. Wainwright
Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright
07/23/20 H.C. Wainwright
Genfit price target lowered to $8 from $11 at H.C. Wainwright
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Stifel
Genfit upgraded to Buy from Hold at Stifel
CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

GNFT Genfit
$3.67 /

-0.28 (-7.09%)

CBAY CymaBay
$6.35 /

+0.125 (+2.01%)

Recommendations
Progenity shares remain undervalued, says Piper Sandler » 05:05
09/25/20
09/25
05:05
09/25/20
05:05
PROG

Progenity

$8.50 /

-0.21 (-2.41%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PROG Progenity
$8.50 /

-0.21 (-2.41%)

PROG Progenity
$8.50 /

-0.21 (-2.41%)

08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
08/17/20 Baird
ACOG bulletin positive for prenatal testing players, says Baird
07/23/20 Piper Sandler
Piper encouraged Progenity settlement finalized, says company fully reserved
07/15/20
Fly Intel: Top five analyst initiations
PROG Progenity
$8.50 /

-0.21 (-2.41%)

  • 19
    Jun
PROG Progenity
$8.50 /

-0.21 (-2.41%)

Hot Stocks
GeoVax Labs announces Nasdaq uplisting, 1-for-20 reverse stock split » 05:04
09/25/20
09/25
05:04
09/25/20
05:04
GOVX

GeoVax Labs

$0.00 /

+ (+0.00%)

Concurrent with its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOVX GeoVax Labs
$0.00 /

+ (+0.00%)

GOVX GeoVax Labs
$0.00 /

+ (+0.00%)

Recommendations
Repare Therapeutics viewed as core long-term holding at Piper Sandler » 05:02
09/25/20
09/25
05:02
09/25/20
05:02
RPTX

Repare Therapeutics

$30.05 /

-2.79 (-8.50%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPTX Repare Therapeutics
$30.05 /

-2.79 (-8.50%)

RPTX Repare Therapeutics
$30.05 /

-2.79 (-8.50%)

07/14/20
Fly Intel: Top five analyst initiations
07/14/20 Morgan Stanley
Repare Therapeutics initiated with an Overweight at Morgan Stanley
07/14/20 Goldman Sachs
Repare Therapeutics initiated with a Neutral at Goldman Sachs
07/14/20 Piper Sandler
Repare Therapeutics initiated with an Overweight at Piper Sandler
RPTX Repare Therapeutics
$30.05 /

-2.79 (-8.50%)

  • 19
    Jun
RPTX Repare Therapeutics
$30.05 /

-2.79 (-8.50%)

Initiation
eHealth initiated with a Buy at Goldman Sachs » 05:00
09/25/20
09/25
05:00
09/25/20
05:00
EHTH

eHealth

$70.41 /

-2.01 (-2.78%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHTH eHealth
$70.41 /

-2.01 (-2.78%)

EHTH eHealth
$70.41 /

-2.01 (-2.78%)

09/08/20 SVB Leerink
eHealth upgraded to Outperform from Market Perform at SVB Leerink
08/19/20 Cantor Fitzgerald
eHealth COO departure not cause for concern, says Cantor Fitzgerald
07/27/20 Raymond James
eHealth price target lowered to $115 from $165 at Raymond James
07/24/20 SunTrust
eHealth price target lowered to $200 from $250 at SunTrust
EHTH eHealth
$70.41 /

-2.01 (-2.78%)

  • 04
    Mar
EHTH eHealth
$70.41 /

-2.01 (-2.78%)

EHTH eHealth
$70.41 /

-2.01 (-2.78%)

EHTH eHealth
$70.41 /

-2.01 (-2.78%)

Initiation
Utz Brands initiated with a Neutral at Goldman Sachs » 04:58
09/25/20
09/25
04:58
09/25/20
04:58
UTZ

Utz Brands

$17.09 /

-0.16 (-0.93%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UTZ Utz Brands
$17.09 /

-0.16 (-0.93%)

UTZ Utz Brands
$17.09 /

-0.16 (-0.93%)

09/18/20
Fly Intel: Top five analyst initiations
09/18/20 Citi
Utz Brands initiated with a Buy at Citi
09/16/20
Fly Intel: Top five analyst initiations
09/16/20 Piper Sandler
Utz Brands initiated with a Neutral at Piper Sandler
UTZ Utz Brands
$17.09 /

-0.16 (-0.93%)

Upgrade
Prada upgraded to Neutral from Sell at Goldman Sachs » 04:56
09/25/20
09/25
04:56
09/25/20
04:56
PRDSY

Prada

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRDSY Prada
$0.00 /

+ (+0.00%)

06/24/20 Morgan Stanley
Prada upgraded to Overweight from Equal Weight at Morgan Stanley
06/23/20 Deutsche Bank
Prada downgraded to Hold from Buy at Deutsche Bank
06/17/20 JPMorgan
Prada price target raised to HK$30 from HK$28 at JPMorgan
05/07/20 HSBC
Prada price target lowered to HK$23 from HK$27 at HSBC
General news
Week of 9/25 Baker-Hughes Rig Count to be released at 13:00  04:55
09/25/20
09/25
04:55
09/25/20
04:55
 
General news
Durable Goods Orders to be reported at 08:30 » 04:55
09/25/20
09/25
04:55
09/25/20
04:55

August Durable Goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Durable Goods Orders Ex-Transportation to be reported at 08:30 » 04:55
09/25/20
09/25
04:55
09/25/20
04:55

August Durable Goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Alkermes management to meet virtually with Mizuho » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
ALKS

Alkermes

$16.56 /

-0.26 (-1.55%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$16.56 /

-0.26 (-1.55%)

ALKS Alkermes
$16.56 /

-0.26 (-1.55%)

08/21/20 Mizuho
Alkermes comments on FDA panel may pressure shares, says Mizuho
07/30/20 Mizuho
Alkermes price target raised to $19 from $16 at Mizuho
07/30/20 Goldman Sachs
Alkermes downgraded to Sell from Neutral at Goldman Sachs
06/19/20 Piper Sandler
Biogen price target lowered to $260 from $307 at Piper Sandler
ALKS Alkermes
$16.56 /

-0.26 (-1.55%)

Conference/Events
Applied Genetic management to meet virtually with Roth Capital » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
AGTC

Applied Genetic

$4.72 /

-0.16 (-3.28%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGTC Applied Genetic
$4.72 /

-0.16 (-3.28%)

AGTC Applied Genetic
$4.72 /

-0.16 (-3.28%)

09/09/20 Roth Capital
Roth bumps up Applied Genetic price target to $26 after earnings, XLRP updates
09/03/20 Cantor Fitzgerald
Cantor sees positive risk/reward for Applied Genetic ahead of XLRP update
07/17/20 H.C. Wainwright
H.C. Wainwright says Applied Genetic still in 'pole position' in XLRP
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
AGTC Applied Genetic
$4.72 /

-0.16 (-3.28%)

  • 07
    Feb
Conference/Events
Altimmune participates in a conference call hosted by JMP Securities » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
ALT

Altimmune

$12.03 /

-0.5 (-3.99%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$12.03 /

-0.5 (-3.99%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
08/25/20 Piper Sandler
Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler
08/25/20 JMP Securities
Altimmune's AdCOVID to have 'unique advantages' over other vaccines, says JMP
ALT Altimmune
$12.03 /

-0.5 (-3.99%)

  • 14
    Jul
ALT Altimmune
$12.03 /

-0.5 (-3.99%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

Conference/Events
MKM Partners oil & gas analyst to host analyst/industry conference call » 04:55
09/25/20
09/25
04:55
09/25/20
04:55

Analyst Gerdes will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS restaurant analyst to hold an analyst/industry conference call » 04:55
09/25/20
09/25
04:55
09/25/20
04:55

Restaurants Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
FTI Consulting management to meet virtually with Truist » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
FCN

FTI Consulting

$106.54 /

+1.33 (+1.26%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCN FTI Consulting
$106.54 /

+1.33 (+1.26%)

FCN FTI Consulting
$106.54 /

+1.33 (+1.26%)

05/01/20 Sidoti
FTI Consulting upgraded to Buy from Neutral at Sidoti
04/15/20 Sidoti
FTI Consulting downgraded to Neutral from Buy at Sidoti
04/06/20 William Blair
FTI Consulting upgraded to Outperform from Market Perform at William Blair
01/17/20 SunTrust
FTI Consulting price target raised to $155 from $130 at SunTrust
FCN FTI Consulting
$106.54 /

+1.33 (+1.26%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
LLY

Eli Lilly

$148.89 /

-1 (-0.67%)

, MRNA

Moderna

$65.34 /

-1.81 (-2.70%)

, GS

Goldman Sachs

$195.12 /

+9.05 (+4.86%)

Next Phase of Healthcare,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MRNA Moderna
$65.34 /

-1.81 (-2.70%)

GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MRNA Moderna
$65.34 /

-1.81 (-2.70%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MRNA Moderna
$65.34 /

-1.81 (-2.70%)

GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

  • 19
    May
  • 12
    Feb
LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MRNA Moderna
$65.34 /

-1.81 (-2.70%)

GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MRNA Moderna
$65.34 /

-1.81 (-2.70%)

GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MRNA Moderna
$65.34 /

-1.81 (-2.70%)

GS Goldman Sachs
$195.12 /

+9.05 (+4.86%)

Conference/Events
Southern Company management to meet virtually with KeyBanc » 04:55
09/25/20
09/25
04:55
09/25/20
04:55
SO

Southern Company

$53.03 /

+0.51 (+0.97%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SO Southern Company
$53.03 /

+0.51 (+0.97%)

SO Southern Company
$53.03 /

+0.51 (+0.97%)

09/21/20 Barclays
Southern Company upgraded to Overweight from Equal Weight at Barclays
09/10/20
Fly Intel: Top five analyst downgrades
09/10/20 Mizuho
Southern Company downgraded to Underperform on Vogtle concerns at Mizuho
09/10/20 Mizuho
Southern Company downgraded to Underperform from Neutral at Mizuho
SO Southern Company
$53.03 /

+0.51 (+0.97%)

SO Southern Company
$53.03 /

+0.51 (+0.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.